Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566* * Presented at the 34th American Society of Clinical Oncology annual meeting 1998.
Titel:
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566* * Presented at the 34th American Society of Clinical Oncology annual meeting 1998.
Auteur:
Erlichman, C. Adjei, A.A. Alberts, S.R. Sloan, J.A. Goldberg, R.M. Pitot, H.C. Rubin, J. Atherton, P.J. Klee, G.G. Humphrey, R.